A 61-year-old male hemodialysis patient developed the syndrome of aluminum intoxication including bone pain, fractures, proximal myopathy, progressive anemia and expressive aphasia. Serum aluminum was 130 micrograms/l and rose to 445 micrograms/l after the administration of 2 grams of desferrioxamine. Bone biopsy of the iliac crest revealed severe osteomalacia, heavy staining for aluminum and a bone aluminum content of 229 mg/kg dry bone. Treatment with combined hemofiltration and desferrioxamine administration led to a marked clinical improvement and a repeat bone biopsy striking healing of the osteomalacia with a bone aluminum content of 11 mg/kg dry bone.
MatternW.D., KrigmanM.R., BlytheW.B.Failure of successful renal transplantation to reverse the dialysis-associated encephalopathy syndrome.Clin Nephrol1977; 7: 275–278.
5.
BerlyneG.M., Ben-AriJ., PestD.Hyperaluminaemia from aluminum resins in renal failure.Lancet1970; 2: 494–496.
6.
BerlyneG.M.Aluminum toxicity in man.Minteral Electrolyte Metab1979; 2: 71–73.
7.
AckrillP., RalstonA.J., DayJ.P., HodgeK.C.Successful removal of aluminum from patient with dialysis encephalopathy.Lancet1980; 2: 692–693.
8.
NetterP., BurnelD., HutinM.F., KesslerM.F., FaureG.Aluminum in joint tissues of patient taking aluminum hydroxide.Lancet1981; 1: 1056–1057.
9.
ClarksonE.M., LuckV.A., HynsonW.V.The effect of aluminum hydroxide on calcium, phosphorus and aluminum balances, the serum parathyroid hormone concentration and the aluminum content of bone in patients with chronic renal failure.Clin Sci1972; 43: 519–531.
10.
BoukariM., JaudonM.C., RottembourgF.J., LucianiJ., LegrainM., GalliA.Kinetics of serum and urinary aluminum after renal transplantation.Lancet1978; 2: 1044.
11.
PoissonM., MashalyR., LebkiriB.Dialysis encephalopathy: recovery after interruption of aluminum intake.Br Med J1978; 2: 1610–1611.
12.
MasselotJ.P., AdhemarJ.P., JaudonM.C., KleinknechtD., GalliA.Reversible dialysis encephalopathy: role for aluminum-containing gels.Lancet1978; 2: 1386–1387.
13.
PieridesA.M., EdwardsW.G., CullumU., McCallJ.T., EllisH.A.Hemodialysis encephalopathy with osteomalacic fractures and muscle weakness.Kidney Int1980; 18: 115–124.
HodgeK.C., DayJ.P., O'HaraM., AckrillP., RalstonA.J.Critical concentrations of aluminum in water used for dialysis.Lancet1981; 2: 802–803.
16.
AdhemarJ.P., LaederichJ., JaudonM.C., MasselotJ.P., GalliA., KleinknechtD.Removal of aluminum from patients with dialysis encephalopathy.Lancet1980; 2: 1311.
17.
AckrillP., RalstonA.J., DayJ.P., HodgeK.C.Successfull removal of aluminum from patient with dialysis encephalopathy.Lancet1980; 2: 692–693.
18.
GrafH., StummvollH.K., MeisingerV.Desferrioxamine-induced changes of aluminum kinetics during haemodialysis.Proc Europ Dialysis Trans Assoc1981; 1.8: 674–680.
19.
ArzeR.S., ParkinsonI.S., CartilidgeN.E.F., BrittonP., WardM.K.Reversal of aluminum dialysis encephalopathy after desferrioxamine treatment.Lancet1981; 2: 1116.
20.
PogglitschH., PetekW., WawschinekO., HolzerW.Treatment of early stages of dialysis encephalopathy by aluminum depletion.Lancet1981; 2: 1344–1345.
21.
MilneF.J., SharfB., BellP.D., MeyersA.M.Low aluminum water desferrioxamine, and dialysis encephalopathy.Lancet1982; 2: 502.
22.
BrownD.J., DawbornJ.K., HamK.N., XipellJ.M.Treatment of dialysis osteomalacia with desferrioxamine.Lancet1982; 2: 343–345.
23.
AckrillP., DayJ.P., GarstangF.M., HodgeK.C.Treatment of fracturing renal osteodystrophy by desferrioxamine.Proc Eur Dial Transplant Assoc1982; 19: 203–207.
24.
MallucheH.H., SmithA.J., AbreoK., FaugereM.C.The use of desferrioxamine in the management of aluminum accumulation in bone in patient with renal failure.N Engl J Med1984; 311: 140–144.
25.
SegoloniG.P., CanaveseC., D'AmiconeM., LamonS., TalaricoS., VercelloneA.Zinc, copper and magnesium kinetics during desferrioxamine treatment in uremic patients.Nephron1984; 36: 278–279.
26.
SimonP., AngK.S., MeyrierA., AllainP., MaurasY.Desferrioxamine, aluminum, and dialysis.Lancet1983; 2: 512–513.
